These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 9024119)

  • 1. Management of the Zollinger-Ellison syndrome in pregnancy.
    Stewart CA; Termanini B; Sutliff VE; Corleto VD; Weber HC; Gibril F; Jensen RT
    Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):224-33. PubMed ID: 9024119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
    Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
    Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
    Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
    Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection.
    Fraker DL; Norton JA; Saeed ZA; Maton PN; Gardner JD; Jensen RT
    Surgery; 1988 Dec; 104(6):1054-63. PubMed ID: 2904182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
    Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
    World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: the management of Zollinger-Ellison syndrome.
    Maton PN
    Aliment Pharmacol Ther; 1993 Oct; 7(5):467-75. PubMed ID: 7904187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of acid suppressants in patients with Zollinger-Ellison syndrome.
    Maton PN
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():25-35. PubMed ID: 1679671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zollinger-Ellison syndrome. Current concepts in diagnosis and management.
    Wolfe MM; Jensen RT
    N Engl J Med; 1987 Nov; 317(19):1200-9. PubMed ID: 3309661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
    Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
    Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zollinger-Ellison syndrome (gastrinoma). Current diagnosis and treatment.
    Deveney CW; Deveney KE
    Surg Clin North Am; 1987 Apr; 67(2):411-22. PubMed ID: 2882614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Zollinger-Ellison syndrome.
    Maton PN
    Gastroenterologist; 1994 Jun; 2(2):111-8. PubMed ID: 8055236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.
    Metz DC; Soffer E; Forsmark CE; Cryer B; Chey W; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2003 Feb; 98(2):301-7. PubMed ID: 12591045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study.
    Richardson CT; Peters MN; Feldman M; McClelland RN; Walsh JH; Cooper KA; Willeford G; Dickerman RM; Fordtran JS
    Gastroenterology; 1985 Aug; 89(2):357-67. PubMed ID: 2861140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
    Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
    Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.
    Hirschowitz BI; Simmons J; Mohnen J
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1795-806. PubMed ID: 11683694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma.
    Fraker DL; Norton JA; Alexander HR; Venzon DJ; Jensen RT
    Ann Surg; 1994 Sep; 220(3):320-8; discussion 328-30. PubMed ID: 7916560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.
    Norton JA; Cornelius MJ; Doppman JL; Maton PN; Gardner JD; Jensen RT
    Surgery; 1987 Dec; 102(6):958-66. PubMed ID: 2891201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.
    Metz DC; Pisegna JR; Fishbeyn VA; Benya RV; Jensen RT
    World J Surg; 1993; 17(4):468-80. PubMed ID: 8362529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion.
    Maton PN
    Drugs; 1996 Jul; 52(1):33-44. PubMed ID: 8799683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.